Business
Mahindra Holiday & Resorts books lower net in Q2 shares down
Chennai, Nov 2
Time share resort major Mahindra Holidays & Resorts India Ltd closed the second quarter of FY23 with a lower net profit on a higher income.
According to the company, for Q2FY23 it had logged a profit of about Rs 30.90 crore (Q2FY22 profit about Rs 40.55 crore) on an operational revenue of about Rs 283.60 crore (Rs 237.66 crore).
The company's total expenditure for the period under review went up by about Rs 49.75 crore during Q2FY23 as compared to the same period the previous year.
The company's Board that met on Wednesday also decided to shift the registered office from Tamil Nadu to Maharashtra and the alteration to the Memorandum of Association subject to the approval of the shareholders and the central government.
The company's scrip after opening at Rs 286.15 went down and was changing hands at about Rs 279 per share.
3 minutes ago
'This father has seen many such attempts': Vijayan dismisses CMRL-Exalogic case as political vendetta
5 minutes ago
Three more minor girls approach SIT against granite baron Veeramani in abuse case
7 minutes ago
UDF revamps Kerala cultural bodies, Prem Kumar appointed KSFDC chief
3 hours ago
CEC acted arbitrarily, violated poll law: Ex-Kerala CEO Teeka Ram Meena
3 hours ago
One Story. Multiple Perspectives on Love. One Elusive Truth: Pooja Meri Jaan to premiere on Zee 5 Global on October 2
3 hours ago
Asian Games: India women's Kabaddi team clinches fourth gold with win over Iran
3 hours ago
Salman Khan reprimands Rhiti Tiwari: Was the worst diss ever
3 hours ago
Anil Kapoor reveals his wife Sunita went for their honeymoon alone
3 hours ago
U2 return to Dublin school where band was formed 50 years ago
3 hours ago
Cameron Douglas celebrates his ‘family’ Michael Douglas, Catherine Zeta-Jones on their b’days
3 hours ago
Josh Brolin celebrates 10 years with wife Kathryn: My romping partner till death do us part
3 hours ago
Ed Sheeran’s concerts canceled due to storm warnings
3 hours ago
India urges fair pathogen access and benefit sharing under WHO Pandemic Agreement
